OCT 12, 2020 2:30 PM PDT

Researchers Solve Key Problem for Cancer Immunotherapy

WRITTEN BY: Annie Lennon

Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promise, they still don't work for everyone. Now, researchers may have both found why this is- and a way to resolve the issue. 

Checkpoint inhibitors are a type of immunotherapy that work by targeting specific proteins, such as PD-L1, that exist on tumor cells and signal the body's immune system not to attack them. Although effective in some cases, patients can develop resistance to these therapies if their cancer has spread beyond its initial location to form additional tumors on their liver. 

For their study, the researchers simulated this process by implanting mice with cancer cells under the skin and then either in their liver or lungs. In doing so, they found that, unlike in the lungs, cancer cells in the liver were 'uniquely suppressive'. There, it appeared they were able to take advantage of the liver's signaling mechanisms to retrain the immune system to ignore cancer cells both there and elsewhere in the body. 

As such, the researchers found that after anti-PD-1 treatment, mice with secondary cancers in their livers had significantly lower survival rates than those with cancer in their lungs. 

To find out why this was the case, the researchers later conducted single-cell analyses and found that liver tumors were able to change which genes were expressed in regulatory T cells (immune cells that suppress the immune response also known as 'Tregs') and from there, multiple other immune system cells too. Rather than a difference in the quantity of T cells, the researchers found that cancer in the liver led to a difference in their quality. 

As such, the researchers tested two drugs to see if they could override this effect. While both were effective in restoring the efficacy of anti-PD-1 therapy, they found that the second drug, an anti-CLTA-4 compound that targets regulatory T cells directly and depletes their numbers, was more effective. 

"We've never had this kind of precision in immunotherapy in the past," says James Lee, lead author of the research. "What if, right from the start, you could use a drug that depletes Tregs as a complement to immunotherapy in patients with liver metastasis?"

 

Sources: EurekAlertUCSF

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 28, 2022
Genetics & Genomics
A Genetic Cause of Lupus is Identified
APR 28, 2022
A Genetic Cause of Lupus is Identified
Lupus is an autoimmune disease that can impact anyone, but tends to affects women between the ages of 15 and 45. The dis ...
MAY 19, 2022
Neuroscience
The Unconscious Brain at Work
MAY 19, 2022
The Unconscious Brain at Work
A study published in Neuron revealed how different cell types in the cerebral cortex change their activity during genera ...
JUN 10, 2022
Drug Discovery & Development
The consequences of inappropriate antibiotic prescriptions in children
JUN 10, 2022
The consequences of inappropriate antibiotic prescriptions in children
The discovery of antibiotics in the early 1900’s was one of the most important discoveries in medical history. The ...
JUN 17, 2022
Cannabis Sciences
Projected Increases in Cannabis Use in States Legalizing Recreational Cannabis
JUN 17, 2022
Projected Increases in Cannabis Use in States Legalizing Recreational Cannabis
A study published in the scientific journal Addiction found that people will be more likely to use cannabis as their sta ...
JUN 29, 2022
Microbiology
Unleashing the Genetic Power of Ocean Microbes
JUN 29, 2022
Unleashing the Genetic Power of Ocean Microbes
By analyzing over 1,000 samples of the marine environment, researchers have reconstructed the genomes of 25,000 novel mi ...
JUL 01, 2022
Cannabis Sciences
Firefly Genes Provide Insights into Cannabis Biology
JUL 01, 2022
Firefly Genes Provide Insights into Cannabis Biology
A team of University of Connecticut researchers are using firefly genes to understand molecular mechanisms involved in t ...
Loading Comments...